| #199 |
Thomas Little |
Boston University |
1 |
| #199 |
Zihua Wang |
Gpb Scientific |
1 |
| #199 |
Andrew John Carroll |
Twitter |
1 |
| #199 |
John P. Petry |
AMD |
1 |
| #199 |
Chung Chan |
Canon |
1 |
| #199 |
Rob Sellar |
Children'S Medical Center |
1 |
| #199 |
Nancy J. Gettens |
Crane & Co. |
1 |
| #199 |
Bernice A. Cramer |
Bose |
1 |
| #199 |
Martin Hurlimann |
Schlumberger Technology |
1 |
| #199 |
Michael Rosbash |
Brandeis University |
1 |
| #199 |
Sofia Trakhtenberg |
Nike |
1 |
| #199 |
Andy Vidan |
— |
1 |
| #199 |
Calum MacRae |
The General Hospital |
1 |
| #199 |
Mark W. Feinberg |
Brigham and Women's Hospital |
1 |
| #199 |
Marc W. Kirschner |
Harvard University |
1 |
| #199 |
Xavier F. CULLERE |
Sharkninja Operating |
1 |
| #199 |
Jianmin Gao |
Jiangsu University |
1 |
| #199 |
Avrum Spira |
Boston University |
1 |
| #199 |
Alexander Aronov |
Vertex Pharmaceuticals Incorporated |
1 |
| #199 |
Matthew Hyatt Turpin |
Qualcomm |
1 |
| #199 |
Xinyuan Wu |
Hydra Biosciences |
1 |
| #199 |
David J. Salant |
Boston Medical Center |
1 |
| #199 |
Paul Bleicher |
Optum |
1 |
| #199 |
Xian Li |
Beth Israel Deaconess Medical Center |
1 |
| #199 |
Eliezer Zomer |
Charm Sciences |
1 |
| #199 |
Ebrahim Mehran Mestchian |
The Mathworks |
1 |
| #199 |
Mark J. Cartwright |
Harvard University |
1 |
| #199 |
Jay Werb |
Rf Technologies |
1 |
| #199 |
Noa M. Rensing |
Monotony.Ai |
1 |
| #199 |
Daniel J. Mackey |
N-Dia |
1 |
| #199 |
Andre Sharon |
Fraunhofer Usa |
1 |
| #199 |
Eric Higgins |
PepsiCo |
1 |
| #199 |
Kemal Tuncali |
Brigham and Women's Hospital |
1 |
| #199 |
Samia A. Singer |
— |
1 |
| #199 |
Sonja Strah-Pleynet |
Arena Pharmaceuticals |
1 |
| #199 |
Kevin J. Wilson |
Merck |
1 |
| #199 |
Kurt Swanson |
Glaxosmithkline Biologicals Sa |
1 |
| #199 |
Christine Klaus |
Epizyme |
1 |
| #199 |
Laura E. Schwartz |
Monotony.Ai |
1 |
| #199 |
Hudong Chen |
Dassault Systemes Simulia |
1 |
| #199 |
Robert S. Meissner |
Merck |
1 |
| #199 |
Thomas Schwarz |
Bitop Ag |
1 |
| #199 |
Elizabeth M. Charm |
— |
1 |
| #199 |
Mohammed Asmal |
Vertex Pharmaceuticals Incorporated |
1 |